Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 04 Aug 2023
The survival rate for breast cancer in its earliest stages is almost 100%. But that is the case with tumors found at a later stage.
Read Full NewsNot all adrenal incidentalomas need the same workup. The Curbsiders break down when to worry, what to test, and why MACS may be behind your patient's hard-to-control metabolic disease.
Dr Maurie Markman examines new registry data on ovarian cancer diagnostic timing, showing how disease biology can complicate the link between early detection and survival.
Dr Andrea Chadwick describes how the shift from tender points to symptom-based criteria has improved fibromyalgia diagnosis, understanding, and patient-centered care.
Dr Anne Peters discusses the expanding use of continuous glucose monitoring in people with diabetes.
Before you freeze a skin lesion, ask yourself whether you really know what it is. Here are four signs you should biopsy instead of freeze.
EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision from causes unrelated to the targeted disease, sending its...
The FDA has approved a radioactive agent for use in brain scans to help assess patients for Alzheimer's disease.
1.
Guidelines for cervical cancer screening and the risk of preterm birth in young women.
2.
Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?
3.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
4.
Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.
5.
Health researchers discuss Medicaid cancer screening trends, best practices
1.
The Risk Factors of Venous Thromboembolism and How to Lower Your Chances
2.
Precision Oncology Using Tumor Evolutionary Trajectory Modeling
3.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
4.
HKDC1 Protein: An Emerging Therapeutic Target in Colon Cancer
5.
The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
5.
Latest Advances in Hematology
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge